PT Hetzer Medical Indonesia Tbk (IDX:MEDS)

IDX:MEDS Revenue

PT Hetzer Medical Indonesia Tbk had revenue of 4.77B IDR in the quarter ending March 31, 2026, with 162.83% growth. This brings the company's revenue in the last twelve months to 9.58B, up 184.54% year-over-year. In the year 2025, PT Hetzer Medical Indonesia Tbk had annual revenue of 6.63B with 3.73% growth.

• Revenue (ttm): 9.58B
• Revenue Growth: +184.54%
• P/S Ratio: 15.33
• Revenue / Employee: 532.37M
• Employees: 18
• Market Cap: 146.88B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.63B	238.07M	3.73%
Dec 31, 2024	6.39B	-16.33B	-71.87%
Dec 31, 2023	22.72B	-15.01B	-39.79%
Dec 31, 2022	37.74B	-38.05B	-50.21%
Dec 31, 2021	75.79B	-12.00B	-13.67%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 26, 2026

Data Sources Report a data error